155 related articles for article (PubMed ID: 9103674)
21. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia.
Inaba T; Roberts WM; Shapiro LH; Jolly KW; Raimondi SC; Smith SD; Look AT
Science; 1992 Jul; 257(5069):531-4. PubMed ID: 1386162
[TBL] [Abstract][Full Text] [Related]
22. Cell transformation mediated by homodimeric E2A-HLF transcription factors.
Inukai T; Inaba T; Yoshihara T; Look AT
Mol Cell Biol; 1997 Mar; 17(3):1417-24. PubMed ID: 9032268
[TBL] [Abstract][Full Text] [Related]
23. Expression of two types of E2A-HLF fusion proteins in YCUB-2, a novel cell line established from B-lineage leukemia with t(17;19).
Takahashi H; Goto H; Eunabiki T; Fujii H; Yamazaki S; Fujioka K; Ikuta K; Kai S
Leukemia; 2001 Jun; 15(6):995-7. PubMed ID: 11417493
[No Abstract] [Full Text] [Related]
24. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
Deucher AM; Qi Z; Yu J; George TI; Etzell JE
Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
Yeung J; Kempski H; Neat M; Bailey S; Smith O; Brady HJ
Haematologica; 2006 Mar; 91(3):422-4. PubMed ID: 16531271
[TBL] [Abstract][Full Text] [Related]
26. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K
Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: characterization and diagnostic utility.
Sang BC; Shi L; Dias P; Liu L; Wei J; Wang ZX; Monell CR; Behm F; Gruenwald S
Blood; 1997 Apr; 89(8):2909-14. PubMed ID: 9108411
[TBL] [Abstract][Full Text] [Related]
29. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice.
Kamps MP; Baltimore D
Mol Cell Biol; 1993 Jan; 13(1):351-7. PubMed ID: 8093327
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis.
Hunger SP
Blood; 1996 Feb; 87(4):1211-24. PubMed ID: 8608207
[No Abstract] [Full Text] [Related]
31. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
32. The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1.
Dang J; Inukai T; Kurosawa H; Goi K; Inaba T; Lenny NT; Downing JR; Stifani S; Look AT
Mol Cell Biol; 2001 Sep; 21(17):5935-45. PubMed ID: 11486032
[TBL] [Abstract][Full Text] [Related]
33. Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia.
Yamasaki N; Miyazaki K; Nagamachi A; Koller R; Oda H; Miyazaki M; Sasaki T; Honda ZI; Wolff L; Inaba T; Honda H
Oncogene; 2010 Apr; 29(13):1963-75. PubMed ID: 20062079
[TBL] [Abstract][Full Text] [Related]
34. E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype.
Dahéron L; Brizard F; Millot F; Cividin M; Lacotte L; Guilhot F; Brizard A
Hematol J; 2002; 3(3):153-6. PubMed ID: 12111652
[TBL] [Abstract][Full Text] [Related]
35. Frequent expression of human Thy-1 antigen on pre-B cell acute lymphoblastic leukemia with t(9;22).
Takahashi T; Mizutani M; Miwa H; Katayama N; Nishii K; Shikami M; Yamaguchi M; Shiku H; Kamada N; Kita K
Int J Hematol; 1998 Jun; 67(4):369-78. PubMed ID: 9695410
[TBL] [Abstract][Full Text] [Related]
36. TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation.
Ron D
Curr Top Microbiol Immunol; 1997; 220():131-42. PubMed ID: 9103679
[No Abstract] [Full Text] [Related]
37. Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.
Lejman M; Włodarczyk M; Zawitkowska J; Kowalczyk JR
BMC Med Genomics; 2020 Apr; 13(1):58. PubMed ID: 32245383
[TBL] [Abstract][Full Text] [Related]
38. Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia.
Van Dijk MA; Voorhoeve PM; Murre C
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6061-5. PubMed ID: 8327485
[TBL] [Abstract][Full Text] [Related]
39. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
[TBL] [Abstract][Full Text] [Related]
40. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein.
Inukai T; Inoue A; Kurosawa H; Goi K; Shinjyo T; Ozawa K; Mao M; Inaba T; Look AT
Mol Cell; 1999 Sep; 4(3):343-52. PubMed ID: 10518215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]